Biggest News Aggregation in the World
📰 Allogeneic News

Page 2 - Allogeneic News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Allogeneic. Real-time updates on events, politics, business and more.

Vycellix, Inc.: Vycellix Presents Proof-of-Concept Data for VY-UC Allogeneic Cell Therapy Platform at the International Society for Cell & Gene Therapy (ISCT) Annual Meeting, Paris

Single-Step CD45-Engager Strategy Generates Immune-Privileged Cells with Abrogation of Host Cellular Immune Responses Being Developed to Eliminate the Need for Complex, Expensive Gene-Editing Approaches
France General United States Mecklenburg Vorpommern Stefan Klotter Evren Alici Douglasw Calder

Cellectis Showcased Preclinical Data at an Oral Presentation and Two Poster Presentations at the 29th International Society for Cell & Gene Therapy (ISCT 2023) Annual Event

Preclinical data on UCART20x22, Cellectis’ first allogeneic dual CAR T-cell product candidate to treat B-NHL, presented at an oral session Encouraging data presented on gene editing process... | June 5, 2023
North Carolina United States France General New York Ashleyr Robinson Arthur Stril

Allogene Therapeutics Presents Updated ALLO-501/501A Phase 1 Data in Large B Cell Lymphoma at the American Society of Clinical Oncology (ASCO) Annual Meeting

Long Term Follow Up Data from Phase 1 ALPHA/ALPHA2 Trials Demonstrate Potential of Allogeneic CD19 CAR T to Generate Durable Complete Responses Similar to Approved Autologous Therapies Presentation... | June 3, 2023
United States Allogene Allo Madeleine Goldstein Zachary Roberts Christine Cassiano American Society Of Clinical Oncology

Celularity Tissue Factor Gene Knockout of Allogeneic Stromal Cells Significantly Lowers Thrombotic Effects; Study Highlights Critical Importance of Gene Editing Capability

Data published online in the journal Cytotherapy demonstrate that CRISPR-mediated tissue factor gene knockout in allogeneic stromal cells leads to significantly lower tissue factor expression,... | June 1, 2023
Robertj Hariri Celularity Inc Globenewswire Inc Securities Exchange International Society Of Cell Exchange Commission

Precision BioSciences Provides Update on Allogeneic CAR T Programs and Regulatory Path Forward

Azer-Cel Safety Profile was Significantly Improved Compared to Prior Cohorts in Patients Dosed Using Optimized Product at Lower Intensity Lymphodepletion; No Grade 3 or Greater Allogeneic CAR T... | May 31, 2023
Michael Amoroso Precision Biosciences Inc Drug Administration Precision Biosciences Chief Executive Officer Potential First In Class Allogeneic

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Tessa Therapeutics Ltd: Tessa Therapeutics' Autologous and Allogeneic Cell Therapy Data to be Featured at the 17th International Conference on Malignant Lymphoma, Lugano

New data from clinical trials of TT11 and TT11X to be featured in oral and poster presentationsSINGAPORE, May 30, 2023 (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments
Dave Schemelia Wilsonw Cheung Us Food Drug Administration Tiberend Strategic Advisors Inc International Conference On Malignant Lymphoma International Conference

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science